Latvia - Import of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale

Since 2014, Latvia Import of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale increased 10.5% year on year. With €30,423,067.99 in 2019, the country was number 24 among other countries in Import of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Latvia is overtaken by Lithuania, which was ranked number 23 with €46,099,180.05 and is followed by Estonia with €12,383,628.26. Belgium ranked the highest with €2,393,399,077.81 in 2019, a growth of 0.1% compared to 2018. Italy, Germany and France respectively ranked number 2, 3 and 4 in this ranking. Italy witnessed the best average annual growth at +27.3% per year, while Malta was the worst growing country at -38.3% per year.

Loading...

Date Euros
2019 30,423,067.99
2018 30,952,470.00
2017 23,062,370.00
2016 22,561,060.00
2015 20,888,310.00
Download all data from 2001 to 2019

How does Latvia rank in Import of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?

# 27 Countries Euros Last YoY 5‑years CAGR
1 #1
Belgium
2,393,399,077.81 2019 +0.1 % +5.8 % View data
2 #2
Italy
2,264,187,469.68 2019 -5.0 % +27.3 % View data
23 #23
Lithuania
46,099,180.05 2019 +4.6 % +7.4 % View data
24 #24
Latvia
30,423,067.99 2019 -1.7 % +10.5 % View data
25 #25
Estonia
12,383,628.26 2019 +2.5 % -7.3 % View data
Compare all 27 countries

Go Top